<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144757">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097485</url>
  </required_header>
  <id_info>
    <org_study_id>Ha03-008</org_study_id>
    <nct_id>NCT02097485</nct_id>
  </id_info>
  <brief_title>Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation</brief_title>
  <official_title>A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hatchtech Pty Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hatchtech Pty Ltd</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Australia: Therapeutic Goods Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate ovicidal efficacy of a single application of
      abametapir lotion 0.74% w/w intended for the treatment of head lice.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Proportion of hatched eggs pre treatment relative to proportion of hatched eggs post treatment for the abametapir and vehicle treated eggs following 14 day incubation.</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Head Lice Infestation</condition>
  <arm_group>
    <arm_group_label>Abametapir Lotion 0.74% w/w</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topically administered to hair and scalp for 10 minutes application.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle Lotion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administered to scalp and hair for 10 minutes application.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Abametapir Lotion 0.74% w/w</intervention_name>
    <description>200mL abametapir lotion topically administered to the scalp and hair and once fully saturated left for 10 minutes and then washed out thoroughly with warm water.</description>
    <arm_group_label>Abametapir Lotion 0.74% w/w</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vehicle Lotion</intervention_name>
    <description>control to abametapir: 200mL Vehicle Lotion topically administered to the scalp and hair and once fully saturated left for 10 minutes and then washed out thoroughly with warm water.</description>
    <arm_group_label>Vehicle Lotion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy male or female based on medical history

          2. Six months of age or older.

          3. Has an active head lice infestation with a minimum of 3 live head lice and at least
             10 undamaged and unhatched head lice eggs in their hair.

          4. Agrees to an examination for head lice and compliance with the study procedures.

          5. All adult subjects must sign a written voluntary informed consent.  For minors, the
             parent/ legal guardian agrees to the subject participating in the study as determined
             by the signing of an assent of informed consent.

        Exclusion Criteria:

          1. Has scalp disease or a history of allergies or prior reactions to any head lice
             products.

          2. Has a condition that, in the opinion of the Investigator, may interfere with the
             study.

          3. Is receiving systemic or topical medication, which in the opinion of the
             Investigator, may compromise the integrity of the safety and/or efficacy assessments.

          4. Had treatment (over-the-counter (OTC) or home remedy medication) for head lice within
             14 days prior to Day 0.

          5. Has received an investigational agent within 30 days prior to Day 0.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Scott Arnold, MBBS</last_name>
    <email>irondoc@bigpond.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Head Lice Treatment Centre</name>
      <address>
        <city>Ringwood East</city>
        <state>Victoria</state>
        <zip>3135</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>March 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parasitic Diseases</mesh_term>
    <mesh_term>Mite Infestations</mesh_term>
    <mesh_term>Lice Infestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
